Frontlight ResearchEarly access
CompletedNo phase
Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib.
Key facts
- Who runs it
- Benha University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 20 people enrolled
- Started
- 1 Jan 2023
- Ended
- 9 Jun 2026
- Type of study
- InterventionalOne group gets an existing treatment, for comparison.
- Treatments tested
- Baricitinib 4 MG Oral Tablet
- Record updated
- 12 June 2026
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Adults diagnosed clinically with Alopecia Areata
- Severity of alopecia tool (SALT) score greater than 50
- Only patients with disease duration exceeding six months but less than eight years will be included
Who cannot take part
- Patients were excluded if they were pregnant or lactating, and had chronic hepatic or renal disease
- Cases diagnosed with malignancy, scalp infections, or other types of alopecia will also excluded from the current study
- Recent use of systemic treatment within the last 3 months or topical treatment within the last 4 weeks also will be excluded
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The primary objective of this study was to evaluate the change in serum interferon gamma and Interleukin-15 levels before and after use of oral drug baricitinib therapy. Venous blood samples (5 mL) were collected from each participant at baseline and at six months.
The group in the trial
- Alopecia Areata adults with severity of alopecia tool more than 50 percent.Existing treatment, for comparison
Adults aged between 18 to 50 years and having a severity of alopecia tool (SALT) score more than 50 pecent.
Treatment: Baricitinib 4 MG Oral Tablet
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment of Serum Level of Interleukin-15 and Interferon Gamma in Alopecia Areata Patients Before and After Baricitinib Treatment
- Record updated
- 12 June 2026